US Patent 9145558 Compositions and methods for modulating HBV expression
Patent 9145558 was granted and assigned to Ionis Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+168 characters)
Article
Patent abstract
Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09145558 Compositions and methods for modulating HBV expression US Patent 9145558 Compositions and methods for modulating HBV expression
Infobox
Patent Number
09145558
Patent Number
9145558
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09145558 Compositions and methods for modulating HBV expression
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09145558
Date of patent
September 29, 2015
Patent application number
14633491
Date Filed
February 27, 2015
Patent primary examiner
Find more entities like US Patent 9145558 Compositions and methods for modulating HBV expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.